The Board and Advisory Team at New Amsterdam Pharma is responsible for guiding the company's strategic direction, overseeing key business decisions, and ensuring successful clinical research and development of cardiometabolic therapies. Composed of board members and clinical advisors, this team provides expert advice, governance, and industry insights to help achieve the company's mission of improving patient care where traditional treatments fall short.
View all